Nancy Lurker, Executive Vice Chair at EyePoint Pharmaceuticals, Inc. (EYPT), sold 70,000 shares at $24.98 ($1.7M) on 2024-01-24, disclosed to the SEC on 2024-01-25.
Scheduled sale ($1.7M) by Executive Vice Chair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.97 | 5,044 | $126K | 7.2% |
| 2 | $24.97 | 5,044 | $126K | 7.2% |
| 3 | $24.98 | 29,956 | $748K | 42.8% |
| 4 | $24.98 | 29,956 | $748K | 42.8% |
| Total | $24.98 avg | 70,000 | $1.7M | 100% |
| Filing → |
| EYPT | SELL | 2025-12-01 | $10K | — | Filing → |
| EYPT | BUY | 2024-08-20 | $25K | — | Filing → |
| EYPT | SELL | 2023-12-06 | $830K | — | Filing → |